Growth factors and renal cancer: characterization and therapeutic implications.
The heterogeneiety renal-cell carcinoma can lead to unpredictable behavior: the ability to achieve a large volume yet not metastasize, the ability to demonstrate late recurrence or spontaneous regression, or the capability to metastasize at a relatively small volume. One-third of all patients who undergo radical nephrectomy for presumed localized disease will eventually have metastasis. Since renal-cell carcinoma is not significantly radio- or chemosensitive, it is important to investigate new avenues for treatment of this tumor once it has spread, specifically at the molecular level. This review discusses the most recent work on growth factors and renal cancer and proposes possible modalities for treatment.
Mydlo
J H
JH
Department of Urology, State University of New York Health Science Center at Brooklyn 11203, USA.
D000818:Animals; D014408:Biomarkers, Tumor; D006133:Growth Substances / Q000378:metabolism*; D006801:Humans; D007680:Kidney Neoplasms / Q000098:blood supply / Q000378:metabolism* / Q000628:therapy*; D009389:Neovascularization, Pathologic / Q000209:etiology / Q000473:pathology; D011379:Prognosis
D014408:Biomarkers, Tumor; D006133:Growth Substances